Author
R. I. Johnson
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2023 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 26 mutual co-author links5 papers
Recent·Most cited
- Cell BiologybioRxivPreprintDOI 10.1101/2023.10.18.562854
- ImmunologybioRxivPreprint
Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody Cocktail
P. A. Nikitin, J. M. DiMuzio, J. P. Dowling…·M. K. Robinson
The paper identifies and characterizes an antibody cocktail, IMM-BCP-01, that neutralizes SARS-CoV-2 variants in vitro and inhibits infection in vivo through Spike Trimer dissociation and effector responses.
DOI 10.1101/2021.10.18.464900 - MicrobiologyNature Structural & Molecular BiologyPeer-reviewed
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro
T. Xiao, J. Lu, J. Zhang…·B. Chen
This study creates a trimeric ACE2 variant with high affinity for SARS-CoV-2 spike protein and shows it inhibits viral infection in cell culture.
DOI 10.1038/s41594-020-00549-3 - ImmunologybioRxivPreprint
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates
N. Zabaleta, W. Dai, U. Bhatt…·L. H. Vandenberghe
This paper evaluates an AAV-based COVID-19 vaccine in mice and non-human primates, showing sustained neutralizing antibodies and memory T-cells, with room-temperature stability and scalable production.
DOI 10.1101/2021.01.05.422952 - MicrobiologybioRxiv
Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2
S. A. Clark, L. E. Clark, J. Pan…·J. Abraham
The paper identifies germline-biased neutralizing antibodies against SARS-CoV-2 and shows that affinity gains do not always correlate with neutralization potency.
DOI 10.1016/j.cell.2021.03.027